We are live on ! Find out more
NRC icon

NRC Health Common Stock

124 hedge funds and large institutions have $499M invested in NRC Health Common Stock in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 50 increasing their positions, 36 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 9

39% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 36

21% more capital invested

Capital invested by funds: $414M → $499M (+$84.8M)

7% more funds holding

Funds holding: 116124 (+8)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.84% less ownership

Funds ownership: 47.38%46.54% (-0.84%)

Holders
124
Holders Change
+8
Holders Change %
+6.9%
% of All Funds
1.98%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
50
Reduced
36
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Kayne Anderson Rudnick Investment Management
1
Kayne Anderson Rudnick Investment Management
California
$140M -$565K -12,785 -0.4%
BlackRock
2
BlackRock
New York
$44.1M +$1.18M +26,792 +3%
Morgan Stanley
3
Morgan Stanley
New York
$41.8M -$559K -12,655 -1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$37.4M -$45.4K -1,029 -0.1%
CCA
5
Conestoga Capital Advisors
Pennsylvania
$31.9M +$269K +6,097 +0.8%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$27.4M -$20.9K -474 -0.1%
QI
7
QV Investors
Alberta, Canada
$19.6M +$25.6K +580 +0.1%
Renaissance Technologies
8
Renaissance Technologies
New York
$16M +$75.1K +1,700 +0.5%
State Street
9
State Street
Massachusetts
$14.2M +$519K +11,746 +4%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$13.4M +$189K +4,291 +1%
Northern Trust
11
Northern Trust
Illinois
$12.2M +$130K +2,947 +1%
TC
12
Touchstone Capital
Pennsylvania
$11.9M -$34.8K -788 -0.3%
NEI
13
Northwest & Ethical Investments
Ontario, Canada
$7.84M
Bank of New York Mellon
14
Bank of New York Mellon
New York
$5.73M +$65.1K +1,474 +1%
Bank of America
15
Bank of America
North Carolina
$4.79M +$538K +12,189 +12%
Charles Schwab
16
Charles Schwab
California
$4.56M +$50.1K +1,135 +1%
Wells Fargo
17
Wells Fargo
California
$4.55M -$37.5K -849 -0.8%
Ohio Public Employees Retirement System (OPERS)
18
Ohio Public Employees Retirement System (OPERS)
Ohio
$3.8M
MAM
19
Montanaro Asset Management
United Kingdom
$2.92M
N
20
Nuveen
North Carolina
$2.46M +$5.03K +114 +0.2%
Ameriprise
21
Ameriprise
Minnesota
$2.38M +$640K +14,503 +36%
RA
22
Royce & Associates
New York
$2.11M -$5.83K -132 -0.3%
Daiwa Securities Group
23
Daiwa Securities Group
Japan
$2.11M -$190K -4,300 -8%
Select Equity Group
24
Select Equity Group
New York
$2.08M +$240K +5,424 +13%
Bessemer Group
25
Bessemer Group
New Jersey
$2.06M

NRC Hedge Fund Activity: Q1 2023 in Review

124 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q1 2023, worth a combined $499M — up 21% from $414M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new NRC positions and 9 closed out — a net gain of 9 holders — while 50 added to existing stakes and 36 trimmed.

The largest buyer was BlackRock, adding an estimated $1.18M. The largest seller was Victory Capital Management, cutting an estimated $5.05M.

  • 124 institutional investors held NRC Health Common Stock (NRC) as of Q1 2023, up from 116 in Q4 2022.
  • Funds reported $499M of NRC Health Common Stock stock for Q1 2023, up 21% quarter-over-quarter.
  • 18 funds opened new NRC Health Common Stock positions in Q1 2023 and 9 closed out, a net change of +9 holders.
  • The largest NRC Health Common Stock buyer in Q1 2023 was BlackRock, an estimated $1.18M added.
  • The largest NRC Health Common Stock seller in Q1 2023 was Victory Capital Management, an estimated $5.05M sold.

Based on aggregated 13F filings for Q1 2023.